δ-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
US7358240B2 · kind B2 · utility
1Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2006 |
| Grant date | Apr 15, 2008 |
| Priority date | — |
| Expiry date | Oct 9, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A δ-crystalline form of ivabradine hydrochloride of formula (I):characterised by its powder X-ray diffraction data.Medicinal products containing the same which are useful as bradycardics.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.